報價延遲最少15分鐘:2025/11/27 20:39 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
883.71 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
31.99/41.68
|
|
企業價值
115.70B
|
| 資產負債 |
|
每股賬面淨值
-14.09
|
| 現金流量 |
|
現金流量率
0.06
|
| 損益表 |
|
收益
16.91B
|
|
每股收益
2,358.47
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies. |
